Elin Jäger/LinkedIn
Aug 24, 2026, 13:19
Elin Jäger: NNHF First-Half 2026 Programme Report
Elin Jäger, Senior Vice President, Chief of Staff and Head of CEO Office, Corporate Strategy and Sustainability at Novo Nordisk, shared a post on LinkedIn:
“What does progress look like?
As a member of the Novo Nordisk Haemophilia & Haemoglobinopathies Foundation Council, I’ve seen it’s rarely one big moment – it’s built locally, over time and together.
A few highlights from the NNHF First-Half 2026 Programme Report:
- Mozambique: mor than 180 healthcare professionals trained in haemophilia care
- Nigeria: 74 stakeholders united to launch a Technical Working Group on inherited blood disorders
- Across regions: from East Africa to the Caribbean, partners are sharing expertise across borders.
What does lasting progress in haemophilia care look like where you are?”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning